Related Experiment Videos
Surrogate markers and clinical pharmacology
1Harris Laboratories, Phoenix, Arizona 85040, USA.
Journal of Clinical Pharmacology
|May 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Thalidomide dose proportionality assessment following single doses to healthy subjects.
Journal of clinical pharmacology·2001
Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development.
Journal of clinical pharmacology·2001
Pharmacokinetic/pharmacodynamic modeling in drug research and development.
Journal of clinical pharmacology·2001
Hemoglobin and methemoglobin concentrations after large-dose infusions of diaspirin cross-linked hemoglobin.
Anesthesia and analgesia·2001
Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women.
Biopharmaceutics & drug disposition·2000
An evolution of drug development and clinical pharmacology during the 20th century.
Journal of clinical pharmacology·2000
Clinical Pharmacology in China: Seven Decades of Progress in Discipline Development and Education.
Journal of clinical pharmacology·2026
Semaglutide-Induced Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.
Journal of clinical pharmacology·2026
Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.
Journal of clinical pharmacology·2026
Bayesian-Estimated Vancomycin AUC24 as a Near-Term Renal Risk Signal after Therapeutic Drug Monitoring: A Multicenter Cohort Study.
Journal of clinical pharmacology·2026